Euronext Growth Rule 26 Information
The following information is disclosed in accordance with Rule 26 of the Euronext Growth Rules for Companies published by Euronext Dublin.
Description of the business
Please click on the link below for a description of the business.
Business Overview »
Names of the directors and biographical details
Please click on the link below for the names of the directors and brief biographical details of each.
Board Responsibilities and Committees
Please click on the link below for a description of directors’ responsibilities.
Board Responsibilities and Committees »
Country of incorporation
Mainstay Medical International plc is incorporated in Ireland (registered number 539688) and has subsidiaries operating in Ireland (Mainstay Medical Limited and Mainstay Medical Distribution Limited), Germany (Mainstay Medical GmbH), the United States (MMLUS Inc.) and Australia (Mainstay Medical (Australia) Pty Limited).
Current constitutional documents
Please click on the link below for a copy of the Company’s Memorandum and Articles of Association.
Memorandum and Articles of Association ».
Securities in issue
Number of Ordinary Shares in issue is 13,421,504
The percentage of Ordinary Shares in issue not in public hands is 74.2%
Details of any restriction on the transfer of securities
There are no restrictions on the transfer of ordinary shares.
As at 01 August 2019, the Company has been notified of the following holdings of 3% or more in its ordinary share capital.
|Shareholder||Ordinary Shares held||% of Ordinary Share Capital|
|Fountain Healthcare Partners||2,268,553||16.9%|
|RICA Universal, S.A.||1,064,935||7.9%|
|Seamus Mulligan 2||772,039||5.8%|
|The Ireland Strategic Investment Fund (ISIF)||714,285||5.3%|
2 includes ordinary shares held by Barrymore Investments Limited and Nerano Capital Limited.
Please click on the link below for information on the Company’s corporate governance.
Corporate governance »
Mainstay Medical International plc ordinary shares are listed on Euronext Paris (MSTY.PA) and Euronext Growth operated by Euronext Dublin (MSTY.IE).
Irish Takeover Rules
As a company with its registered office in Ireland and whose securities are admitted to trading on a regulated market (within the meaning of Directive 93/22/EEC) in France only, the Company is, for the purposes of Directive 2004/25/EC of the European Parliament and the Council dated 21 April 2004 (the “Takeover Directive”), a shared jurisdiction company. This means that a takeover offer or bid for its securities would be subject to the Irish Takeover Rules of the Irish Takeover Panel in some respects, but also subject to the general regulation (règlement général) (the “French Takeover Rules”) of the Autorité des marchés financiers (the “AMF”) in many respects.
Please click on the link below to access Company announcements.
Regulatory News »
Please click on the link below to access Company results and management statements.
Company Results »
Admission document and circulars
Please click on the below to access the Company’s Prospectus, which also comprises an admission document in relation to Euronext Growth.
Admission Documents »
Annual General Meeting 2015 Documents »
Annual General Meeting 2016 Documents »
Annual General Meeting 2017 Documents »
Annual General Meeting 2018 Documents »
Annual General Meeting 2019 Documents »
Please click on the link below for a list of the Company’s Euronext Adviser and other key advisers.